South Korea’s CRScube has expanded its European customer based and announced plans to seek more new drug industry and CRO customers in the region.
The electronic clinical solutions provider announced the new deals this week.
While it stopped short of naming its new partners, it did confirm the first deal is with a Stockholm, Sweden-based firm that will use its electronic data capture (EDC), clinical trial management system (CTMS), electronic trial master file (eTMF) and interactive web response system (IWRS) in an upcoming study.
The second deal is with a contract research organization (CRO) in Poland that will use CRScube's EDC and IWRS for a series of new clinical trials, with the first study already in development.
According to the CRScube's partnerships will solidify its position as a reliable and trusted partner for eClinical solutions in Europe.
A spokesman hinted the firm would seek more partnerships in the region, explaining “CRScube is delighted to expand our services in Europe through these partnerships.
"Our advanced and comprehensive suite of eClinical solutions has enabled us to help our clients streamline their clinical trials, and we look forward to working with more clients in Europe."
Seoul-headquartered CRScube claims to have worked on over 4,400 clinical trials – including for several partners in Taiwan. The firm was established in 2010 with the aim of providing eClinical solutions companies and CROs.
Over the past decade, CRScube has opened offices in China, Japan, and the US, and is expanding its reach with partners in sub-Saharan Africa, Europe and Latin America.
In October 2021, CRScube established Spero, a subsidiary that focuses on the provision of technologies and services that support decentralized clinical trials (DCT).
More recently, CRScube acquired in Gyeonggi-do, South Korea –based BDM Consulting, a contract research organization (CRO) that provides biostatistics, SAS programming, and data management services.
Unsplash/jannerboy62